97 related articles for article (PubMed ID: 28726105)
21. Expression analysis of the estrogen receptor target genes in renal cell carcinoma.
Liu Z; Lu Y; He Z; Chen L; Lu Y
Mol Med Rep; 2015 Jan; 11(1):75-82. PubMed ID: 25351113
[TBL] [Abstract][Full Text] [Related]
22. Increased Expression of Androgen Receptor mRNA in Human Renal Cell Carcinoma Cells is Associated with Poor Prognosis in Patients with Localized Renal Cell Carcinoma.
Ha YS; Lee GT; Modi P; Kwon YS; Ahn H; Kim WJ; Kim IY
J Urol; 2015 Nov; 194(5):1441-8. PubMed ID: 25796113
[TBL] [Abstract][Full Text] [Related]
23. The prospect of precision therapy for renal cell carcinoma.
Ciccarese C; Brunelli M; Montironi R; Fiorentino M; Iacovelli R; Heng D; Tortora G; Massari F
Cancer Treat Rev; 2016 Sep; 49():37-44. PubMed ID: 27453294
[TBL] [Abstract][Full Text] [Related]
24. Flux balance analysis predicts essential genes in clear cell renal cell carcinoma metabolism.
Gatto F; Miess H; Schulze A; Nielsen J
Sci Rep; 2015 Jun; 5():10738. PubMed ID: 26040780
[TBL] [Abstract][Full Text] [Related]
25. Activation of aryl hydrocarbon receptor promotes invasion of clear cell renal cell carcinoma and is associated with poor prognosis and cigarette smoke.
Ishida M; Mikami S; Shinojima T; Kosaka T; Mizuno R; Kikuchi E; Miyajima A; Okada Y; Oya M
Int J Cancer; 2015 Jul; 137(2):299-310. PubMed ID: 25523818
[TBL] [Abstract][Full Text] [Related]
26. Elevated S100A6 (Calcyclin) enhances tumorigenesis and suppresses CXCL14-induced apoptosis in clear cell renal cell carcinoma.
Lyu XJ; Li HZ; Ma X; Li XT; Gao Y; Ni D; Shen DL; Gu LY; Wang BJ; Zhang Y; Zhang X
Oncotarget; 2015 Mar; 6(9):6656-69. PubMed ID: 25760073
[TBL] [Abstract][Full Text] [Related]
27. Extensive decoupling of metabolic genes in cancer.
Reznik E; Sander C
PLoS Comput Biol; 2015 May; 11(5):e1004176. PubMed ID: 25961905
[TBL] [Abstract][Full Text] [Related]
28. High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.
Kruck S; Merseburger AS; Hennenlotter J; Scharpf M; Eyrich C; Amend B; Sievert KD; Stenzl A; Bedke J
BJU Int; 2012 May; 109(10):1565-70. PubMed ID: 21981759
[TBL] [Abstract][Full Text] [Related]
29. Metabolomics and Metabolic Reprogramming in Kidney Cancer.
Weiss RH
Semin Nephrol; 2018 Mar; 38(2):175-182. PubMed ID: 29602399
[TBL] [Abstract][Full Text] [Related]
30. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
[TBL] [Abstract][Full Text] [Related]
31. Transcriptome network analysis reveals candidate genes for renal cell carcinoma.
Zhai W; Xu YF; Liu M; Zheng JH
J Cancer Res Ther; 2012; 8(1):28-33. PubMed ID: 22531510
[TBL] [Abstract][Full Text] [Related]
32. Temporal Identification of Dysregulated Genes and Pathways in Clear Cell Renal Cell Carcinoma Based on Systematic Tracking of Disrupted Modules.
Wang SM; Sun ZQ; Li HY; Wang J; Liu QY
Comput Math Methods Med; 2015; 2015():313740. PubMed ID: 26543493
[TBL] [Abstract][Full Text] [Related]
33. Myoglobin expression in renal cell carcinoma is regulated by hypoxia.
Behnes CL; Bedke J; Schneider S; Küffer S; Strauss A; Bremmer F; Ströbel P; Radzun HJ
Exp Mol Pathol; 2013 Dec; 95(3):307-12. PubMed ID: 24076247
[TBL] [Abstract][Full Text] [Related]
34. Loss of expression of TIMP3 in clear cell renal cell carcinoma.
Masson D; Rioux-Leclercq N; Fergelot P; Jouan F; Mottier S; Théoleyre S; Bach-Ngohou K; Patard JJ; Denis MG
Eur J Cancer; 2010 May; 46(8):1430-7. PubMed ID: 20194016
[TBL] [Abstract][Full Text] [Related]
35. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.
Wiesener MS; Münchenhagen PM; Berger I; Morgan NV; Roigas J; Schwiertz A; Jürgensen JS; Gruber G; Maxwell PH; Löning SA; Frei U; Maher ER; Gröne HJ; Eckardt KU
Cancer Res; 2001 Jul; 61(13):5215-22. PubMed ID: 11431362
[TBL] [Abstract][Full Text] [Related]
36. Profilin 1 overexpression in renal cell carcinoma.
Minamida S; Iwamura M; Kodera Y; Kawashima Y; Ikeda M; Okusa H; Fujita T; Maeda T; Baba S
Int J Urol; 2011 Jan; 18(1):63-71. PubMed ID: 21091798
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-126 inhibits tumor cell invasion and metastasis by downregulating ROCK1 in renal cell carcinoma.
Zhang GM; Luo L; Ding XM; Dong DH; Li B; Ma XC; Sun LJ
Mol Med Rep; 2016 Jun; 13(6):5029-2036. PubMed ID: 27108693
[TBL] [Abstract][Full Text] [Related]
38. Frequent epigenetic suppression of tumor suppressor gene glutathione peroxidase 3 by promoter hypermethylation and its clinical implication in clear cell renal cell carcinoma.
Liu Q; Jin J; Ying J; Sun M; Cui Y; Zhang L; Xu B; Fan Y; Zhang Q
Int J Mol Sci; 2015 May; 16(5):10636-49. PubMed ID: 25970749
[TBL] [Abstract][Full Text] [Related]
39. A specific gene expression signature characterizes metastatic potential in clear cell renal cell carcinoma.
Sanjmyatav J; Steiner T; Wunderlich H; Diegmann J; Gajda M; Junker K
J Urol; 2011 Jul; 186(1):289-94. PubMed ID: 21600596
[TBL] [Abstract][Full Text] [Related]
40. Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation.
Turner KJ; Moore JW; Jones A; Taylor CF; Cuthbert-Heavens D; Han C; Leek RD; Gatter KC; Maxwell PH; Ratcliffe PJ; Cranston D; Harris AL
Cancer Res; 2002 May; 62(10):2957-61. PubMed ID: 12019178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
